 Home > Medical News > Latest Medical News > Tojo Pharmaceuticals Bevacizumab Approved for Listing

Tojo Pharmaceuticals Bevacizumab Approved for Listing

 Last Update: 2022-01-02
 Source: Internet
 Author: User

Tags

bd medical

blood cell size

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Medical Rubik's Cube Info

On December 1, Toyo Pharmaceuticals announced that its self-developed bevacizumab injection TAB008 (trade name: Puxintin, intended to be used in English Pusintin) was approved by the National Medical Products Administration (NMPA) for the treatment of advanced, Metastatic or recurrent non-squamous non-small cell lung cancer and metastatic colorectal cancer

Bevacizumab is an anti-vascular endothelial cell growth factor monoclonal antibody (anti-VEGF mAb) that can specifically bind to VEGF and block the binding of VEGF to its receptors, thereby reducing angiogenesis and inducing existing blood vessels Degenerate, inhibit tumor growth

Avastin was approved by the FDA for the first time in February 2004, and then successively listed in the European Union, Japan, China and other countries

As a broad-spectrum anti-tumor drug, bevacizumab has become a standard program recommended by the global guidelines for the treatment of a variety of malignant tumors.

At present, in addition to the original research, seven biosimilars of bevacizumab have been approved for marketing in China, namely Qilu Pharmaceutical, Cinda Bio, Hengrui Pharmaceutical, Boan Bio, Biotech, Betta Bio and Toyo Pharmaceutical industry

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.